Gregory L. Weaver, Chief Financial Officer at ATAI Life Sciences N.V. (ATAI), bought 4,666 shares at $15.00 ($70K) on 2021-06-22, disclosed to the SEC on 2021-06-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ALT | BUY | 2025-03-14 | $52K | — | Filing → |
| ATOS | SELL | 2023-11-17 | $33K | — | Filing → |
| ATOS | BUY | 2023-06-20 | $49K | — | Filing → |